Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Rotavirus
Study results from University of Sydney update understanding of rotavirus
March 12th, 2008
According to recent research from Westmead, Australia, "Rotavirus is a common cause of acute gastroenteritis in young children. Two rotavirus vaccines with demonstrated safety and efficacy in large scale clinical trials have recently received universal funding in Australia." "We modelled specific outcomes of disease (hospitalisations, emergency department visits, general practitioner visits, and deaths) and examined the effectiveness and cost-effectiveness of both vaccines in the Australian context. From the healthcare payer perspective, the base-case showed only slightly different results for the two vaccines (Rotarix (R) would cost $60,073/QALY gained and RotaTeq (R)...
Source: Vaccine Weekly (2008-03-12)
|
